Scholarlink

Background <p>Cholesterol, high-density lipoprotein, and glucose (CHG) index, an alternative marker of insulin resistance (IR), play a significant role in predicting cardiovascular diseases. However, its prognostic value in patients with calcific aortic valve stenosis (CAVS) remains unclear.</p> Methods <p>This study included 1175 patients diagnosed with calcific aortic valve stenosis via echocardiography from the First Affiliated Hospital of Sun Yat-sen University. Participants were grouped based on the cut-off value of the CHG index. The association between the CHG index and cardiovascular mortality and all-cause mortality in patients with calcific aortic valve stenosis was evaluated using Cox proportional hazards regression and restricted cubic model spline.</p> Results <p>Among the 1175 patients (mean age 68.91 ± 11.68&#xa0;years, 56.6% male), the median follow-up time was 3.23 [1.15, 6.07] years. In the fully adjusted model, each 1-unit increase in the CHG index was linked to a 53% higher risk of cardiovascular mortality and a 43% higher risk of all—cause mortality. Moreover, compared to the low CHG index group, the high CHG index group had a 1.44—fold higher risk of cardiovascular mortality and a 1.43-fold higher risk of all-cause mortality. The restricted cubic spline model indicated a linear relationship between the CHG index and the risks of cardiovascular mortality (<i>p</i> for nonlinearity = 0.529) and all-cause mortality (<i>p</i> for nonlinearity = 0.436).</p> Conclusion <p>Higher levels of insulin resistance, as assessed by the CHG index, are associated with increased risks of cardiovascular and all-cause mortality in patients with calcific aortic valve stenosis.</p> Trial registration <p>RISk facTOr assessmenT and prognosis modeL construction (ARISTOTLE) study (Registry: ClinicalTrials.gov, TRN: NCT06069232, Registration date: 1 October 2023).</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Association between cholesterol, high-density lipoprotein, and glucose index and risks of cardiovascular and all-cause mortality in patients with calcific aortic valve stenosis: the ARISTOTLE cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月11日

查看全文
  • Zhen Guo,
  • Zhenyu Xiong,
  • Wenjing Zhang,
  • Guanzhong Chen,
  • Mengjie Xie,
  • Ziwei Zhou,
  • Shaozhao Zhang,
  • Menghui Liu,
  • Jiaying Li,
  • Xinxue Liao,
  • Xiaodong Zhuang

摘要

Background

Cholesterol, high-density lipoprotein, and glucose (CHG) index, an alternative marker of insulin resistance (IR), play a significant role in predicting cardiovascular diseases. However, its prognostic value in patients with calcific aortic valve stenosis (CAVS) remains unclear.

Methods

This study included 1175 patients diagnosed with calcific aortic valve stenosis via echocardiography from the First Affiliated Hospital of Sun Yat-sen University. Participants were grouped based on the cut-off value of the CHG index. The association between the CHG index and cardiovascular mortality and all-cause mortality in patients with calcific aortic valve stenosis was evaluated using Cox proportional hazards regression and restricted cubic model spline.

Results

Among the 1175 patients (mean age 68.91 ± 11.68 years, 56.6% male), the median follow-up time was 3.23 [1.15, 6.07] years. In the fully adjusted model, each 1-unit increase in the CHG index was linked to a 53% higher risk of cardiovascular mortality and a 43% higher risk of all—cause mortality. Moreover, compared to the low CHG index group, the high CHG index group had a 1.44—fold higher risk of cardiovascular mortality and a 1.43-fold higher risk of all-cause mortality. The restricted cubic spline model indicated a linear relationship between the CHG index and the risks of cardiovascular mortality (p for nonlinearity = 0.529) and all-cause mortality (p for nonlinearity = 0.436).

Conclusion

Higher levels of insulin resistance, as assessed by the CHG index, are associated with increased risks of cardiovascular and all-cause mortality in patients with calcific aortic valve stenosis.

Trial registration

RISk facTOr assessmenT and prognosis modeL construction (ARISTOTLE) study (Registry: ClinicalTrials.gov, TRN: NCT06069232, Registration date: 1 October 2023).

Graphical abstract